<DOC>
	<DOCNO>NCT00780234</DOCNO>
	<brief_summary>This chemoprevention trial evaluate diabetic agent pioglitazone . Non-diabetic subject risk lung cancer ( base smoking history , lung function testing , atypical cell sputum sample ) receive either placebo pioglitazone chest computerize tomography ( CAT ) scan examination airway bronchoscope start trial 6 month treatment . Compensation provide subject complete trial .</brief_summary>
	<brief_title>Pioglitazone Lung Cancer Chemoprevention</brief_title>
	<detailed_description>This trial evaluate oral peroxisome proliferator-activated receptor gamma ( PPARgamma ) agonist pioglitazone double-blind placebo control trial . The high risk current former smoker qualify base tobacco exposure , airflow limitation lung function testing , sputum cytologic atypia . Subjects quantitative high resolution thoracic CT scan fluorescent bronchoscopy study entry 6 month drug placebo . Biologic sample collect time point . The primary outcome endobronchial histology determine pioglitazone retard progression . Secondary endpoint relate PPAR gamma signal pathway also analyze .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Current former smoker ( least 10 pack year ) ; One following : Mild bad sputum atypia Airflow Limitation ( FEV1/FVC &lt; 70 % predict ) Biopsy proven airway dysplasia myocardial infarction ( MI ) ejection fraction &lt; 50 % ; severe/unstable angina ; history coronary peripheral arterial bypass grafting ; New York Heart Association ( NYHA ) class III IV congestive heart failure ; hypoxemia ( less POX 90 supplemental oxygen ) ; Diabetes type I II ; severe COPD ( GOLD stage III IV ) ; clinically significant edema require diuretic therapy ; life expectancy &lt; 6 month ; history bladder cancer pregnant breast feeding ; inability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>chemoprevention</keyword>
	<keyword>lung cancer</keyword>
	<keyword>pioglitazone</keyword>
</DOC>